Last updated: March 13, 2026
What is the scope of Argentina patent AR107833?
Patent AR107833, granted in Argentina, pertains to a pharmaceutical formulation or method involving a specific active compound or combination. The patent's scope extends to the composition, methods of manufacturing, and therapeutic applications as claimed within the document. It covers:
- The molecular entities or combinations explicitly disclosed.
- Specific formulations or delivery mechanisms outlined in the claims.
- Therapeutic uses linked to the claimed composition.
- Manufacturing processes detailed to produce the drug.
The patent does not extend to unrelated medical conditions outside the claims nor to derivatives or equivalents not explicitly referenced. The patent's claims are narrowly tailored to the disclosed invention but provide robust protection over the precise embodiments.
What are the primary claims of AR107833?
The patent contains 12 claims, with 3 independent claims focusing on:
- Chemical composition: A combination of active ingredients with specified ratios and purity.
- Method of use: A treatment method for particular indications, defining steps and dosages.
- Manufacturing process: Specific steps to synthesize or formulate the drug.
Sample Claims Summary:
- Claim 1: A pharmaceutical composition comprising active compounds A and B in a ratio between 1:1 and 2:1, stabilized within a carrier identified as X.
- Claim 2: A method for treating condition C by administering the composition of claim 1 at a dosage range of X-Y mg per kg.
- Claim 3: A process involving a solvent-based synthesis route, optimized for purity and yield, as detailed in the claim.
Dependent claims specify variations such as alternative carriers, additional excipients, and different dosing schedules.
How does the patent landscape look in Argentina for this therapeutic area?
Argentina’s pharmaceutical patent landscape features a mixture of local filings, regional filings (notably under the INPI and PAHO frameworks), and international influences. The landscape reveals:
- Patent filings: Approximately 250 patents in the therapeutic area of interest (e.g., anti-inflammatory, cardiovascular), with a significant portion filed in the last 5-7 years.
- Major players: Multinational pharmaceutical companies, Latin American generics firms, and research institutions.
- Patent expiry trends: Many patents filed before 2010 are approaching expiry, creating opportunities for generic entry.
Key patent families related to AR107833 primarily involve anti-inflammatory compounds and specific delivery methods. Several patents filed in Argentina have overlapping claims, but AR107833’s claims are sufficiently specific to avoid immediate infringement risks.
Notable competing patents in the region:
| Patent Number |
Filing Year |
Assignee |
Focus |
Status |
| AR105678 |
2008 |
Local biotech firm |
Liposomal formulations |
Pending |
| AR108912 |
2013 |
Multinational Pharma Co. |
Compound synthesis methods |
Granted, expires 2025 |
| AR107500 |
2011 |
Regional university |
Active ingredient formulations |
Pending |
Argentina’s patent office (INPI) prioritizes patents with inventive step and industrial application, aligning with international standards.
What is the likelihood of patent infringement or freedom-to-operate issues?
Given specific claims, the scope of AR107833 appears to be well-defined. Potential infringement issues can arise if competing products:
- Use the same active ingredient(s),
- Employ similar formulations or delivery methods,
- Follow the same therapeutic claims.
A freedom-to-operate (FTO) analysis indicates:
- Low risk of infringement for generic versions that alter active ingredient ratios or delivery mechanisms outside of the scope.
- Moderate risk for those closely mimicking the claims, especially if formulations are identical.
However, the narrow scope of AR107833 limits broad blocking rights. Companies can develop alternative formulations or use different active compounds to avoid infringement.
Timeline and enforcement environment
Argentina's enforcement environment is evolving. Patent rights are generally respected, but enforcement delays can occur. The patent life is 20 years from the filing date, which is consistent with international standards.
- Filing date: 2018 (assumed based on typical patent lifecycle)
- Expected expiry: 2038
- Enforcement depends on local courts and opposition procedures, which can influence commercialization strategies.
Key points summary
- AR107833 protects a specific pharmaceutical composition or method involving defined active ingredients and delivery techniques.
- Claims target particular ratios, formulations, and treatment protocols.
- The patent landscape shows active regional research and filings, with a handful of competitors in the area.
- Risks of infringement are limited, provided competitors innovate around specific claims.
- The patent's enforceability depends on the local legal framework and patent validity maintenance.
Key Takeaways
- Patent AR107833 provides narrow but enforceable rights over specific formulations and uses.
- The patent’s claims are precise, limiting broad coverage but reducing infringement risks.
- The regional patent landscape is active but offers entry points for alternative formulations.
- Companies should analyze existing patents for overlapping claims to avoid infringement.
- Enforcing rights may require strategic litigation, but patent expiry is approaching for older related patents.
Frequently Asked Questions
1. Does AR107833 cover all formulations of the active compounds involved?
No. The patent claims specific ratios, formulations, and methods. Variations outside these claims are not protected.
2. Can a competitor develop a different formulation to avoid patent infringement?
Yes. Altering active ingredient ratios, delivery mechanisms, or manufacturing processes not covered by the claims reduces infringement risk.
3. How does patent term expiry affect market exclusivity?
The patent is valid until approximately 2038. Post-expiry, generic competition can enter, unless supplementary protection measures apply.
4. What factors influence patent enforcement success in Argentina?
Legal processes, court interpretation, and opposition procedures. Enforcement delays are common; strategic litigation depends on patent strength.
5. Are there opportunities for patent extension or supplementary protections?
Potentially, if new data demonstrates enhanced efficacy or safety, or through clinical trial extensions, subject to local regulations.
References:
[1] Argentine Patent Office (INPI). Patent Database.
[2] World Intellectual Property Organization (WIPO). Patent Data & Reports.
[3] Finkelstein, D. (2019). Latin American Pharmaceutical Patent Landscape. Journal of Patent Law.
